Centers for Disease Control and Prevention

Nanomedical Diagnostics launches

Monday, September 21, 2015

Nanomed co-founders Ross Bundy and Dr. Brett Goldsmith have launched Nanomedical Diagnostics, a San Diego-based biotech company developing and commercializing bioelectronics for use in research and diagnostics. Nanomed’s first product, AGILE Research, a label-free, quantitative, low-cost biosensor for small molecule and protein analysis, is entering beta testing this fall and planned for commercial release in early 2016.

[Read More]

NIH launches human RSV study

Monday, August 31, 2015

A new study will expose healthy adult volunteers to respiratory syncytial virus (RSV), a virus that causes cold-like symptoms in adults. Better understanding of how adults develop RSV infection and immune system responses to infection will assist researchers in developing and testing future antivirals and vaccines to combat the virus. The research is being conducted by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

[Read More]

Thermo Fisher Scientific, CDC partner to accelerate global microbial identification

Friday, July 17, 2015

Through a partnership with the Special Bacteriology Reference Laboratory at the Centers for Disease Control and Prevention (CDC), Thermo Fisher Scientific has developed an advanced software solution that enables global public health laboratories to directly access the CDC’s MicrobeNet online virtual reference lab database. Now, researchers can more quickly identify microbial pathogens potentially at the root of global outbreaks without needing to refer to multiple databases by instead utilizing one curated by subject matter experts in the field.

[Read More]

Great Basin wins NIH grant to develop test for CRE superbug

Thursday, July 2, 2015

The National Institute of Allergy and Infectious Diseases, part of the NIH, has awarded a research grant to Great Basin Scientific and Brigham Young University (BYU), to develop a rapid molecular diagnostic test direct from whole blood for carbapenem-resistant Enterobacteriaceae (CRE). The NIH research grant will play a key role in meeting the goals of President Obama’s recent National Action Plan for Combating Antibiotic-Resistant Bacteria.

[Read More]

HHS announces innovation award winners

Thursday, June 25, 2015

Department of Health and Human Services Secretary Sylvia M. Burwell has announced the seven winners of the 2015 HHS Innovates Awards. This annual award program, in its eighth round, recognizes creative solutions developed by HHS employees in response to some of the nation’s most challenging problems in health, health care and government. Winners this year reflected a number of collaborative innovation projects representing seven different operating divisions.

[Read More]

PDI, White House, CDC partner to combat antimicrobial resistance

Thursday, June 4, 2015

PDI, a U.S. healthcare company, has announced a series of corporate commitments designed to educate internal associates and customers about strategies to reduce the threat of antimicrobial-resistant microorganisms as part of its ongoing partnership with the U.S. Centers for Disease Control and Prevention (CDC) and in support of The White House’s National Strategy to Combat Antibiotic-Resistant Bacteria.

[Read More]

West Nile virus vaccine now in phase I clinical trials

Thursday, May 14, 2015

A novel investigational West Nile virus vaccine discovered and developed by scientists at the Oregon National Primate Research Center at Oregon Health & Science University is being evaluated in an NIH-sponsored phase I, first-in-human, clinical trial at Duke University. Although several early-stage West Nile virus vaccine clinical trials have been completed to date, no human vaccine has been approved for commercial use.

[Read More]

Ebola vaccine trial begins in Sierra Leone

Thursday, April 23, 2015

The Centers for Disease Control and Prevention (CDC), in partnership with the Sierra Leone College of Medicine and Allied Health Sciences (COMAHS) and the Sierra Leone Ministry of Health and Sanitation (MoHS), now is enrolling and vaccinating volunteers for the Sierra Leone Trial to Introduce a Vaccine against Ebola (STRIVE). This study will assess the safety and efficacy of the rVSV-ZEBOV candidate Ebola vaccine among health and other frontline workers.

[Read More]

NIH funds nine antimicrobial resistance diagnostics projects

Friday, April 10, 2015

The National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH, has awarded more than $11 million in first-year funding for nine research projects supporting enhanced diagnostics to rapidly detect antimicrobial-resistant bacteria. The awardee institutions will develop tools to identify certain pathogens that frequently cause infections in health care settings and, specifically, those that are resistant to most antimicrobials. Advancing the development of rapid and innovative diagnostic tests for identifying and characterizing resistant bacteria is a key goal of the President’s recent National Action Plan for Combating Antibiotic-Resistant Bacteria.

[Read More]